Rxsight Correlations
| RXST Stock | USD 58.47 1.05 1.76% |
The correlation of Rxsight is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rxsight moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rxsight moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Very weak diversification
The correlation between Rxsight and NYA is 0.41 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rxsight and NYA in the same portfolio, assuming nothing else is changed.
Rxsight |
The ability to find closely correlated positions to Rxsight could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Rxsight when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Rxsight - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Rxsight to buy it.
Moving together with Rxsight Stock
| 0.68 | ESTA | Establishment Labs | PairCorr |
| 0.86 | WGS | GeneDx Holdings Corp | PairCorr |
| 0.67 | INGN | Inogen Inc | PairCorr |
| 0.75 | JYNT | Joint Corp | PairCorr |
Moving against Rxsight Stock
| 0.86 | CVS | CVS Health Corp Buyout Trend | PairCorr |
| 0.81 | VMD | Viemed Healthcare | PairCorr |
| 0.78 | CAH | Cardinal Health Fiscal Year End 20th of August 2024 | PairCorr |
| 0.75 | XTNT | Xtant Medical Holdings | PairCorr |
| 0.72 | WST | West Pharmaceutical | PairCorr |
| 0.7 | SSY | SunLink Health Systems | PairCorr |
| 0.5 | AHG | Akso Health Group | PairCorr |
| 0.5 | FNA | Paragon 28 | PairCorr |
| 0.43 | TFX | Teleflex Incorporated | PairCorr |
| 0.56 | NPCE | Neuropace | PairCorr |
| 0.55 | HSCSW | Heart Test Laboratories | PairCorr |
| 0.52 | NVNO | enVVeno Medical Corp | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Rxsight Stock performing well and Rxsight Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rxsight's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AXGN | 2.50 | (0.69) | 0.00 | (0.45) | 0.00 | 3.86 | 15.90 | |||
| TMCI | 4.10 | (0.80) | 0.00 | (0.24) | 0.00 | 7.67 | 70.17 | |||
| LUNG | 2.71 | (0.40) | 0.00 | (0.13) | 0.00 | 4.69 | 29.06 | |||
| OFIX | 2.04 | 0.06 | 0.02 | 0.08 | 2.75 | 4.28 | 15.45 | |||
| KIDS | 2.57 | 0.20 | 0.07 | 0.17 | 3.02 | 6.44 | 17.32 | |||
| SGHT | 3.29 | 0.71 | 0.16 | 0.79 | 3.38 | 7.54 | 20.95 | |||
| FNA | 3.53 | (0.57) | 0.00 | (0.23) | 0.00 | 7.78 | 31.62 | |||
| SSKN | 3.81 | (0.34) | 0.00 | 0.36 | 0.00 | 8.33 | 30.69 | |||
| NPCE | 3.60 | (1.17) | 0.00 | (0.92) | 0.00 | 6.11 | 50.76 | |||
| VAPO | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Rxsight without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Rxsight Corporate Management
Elected by the shareholders, the Rxsight's board of directors comprises two types of representatives: Rxsight inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rxsight. The board's role is to monitor Rxsight's management team and ensure that shareholders' interests are well served. Rxsight's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rxsight's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Caroline Vaughn | Vice Resources | Profile | |
| Steve Everly | VP Sales | Profile | |
| Rebecca Williston | Vice Finance | Profile | |
| Matt Haller | Chief Officer | Profile | |
| Alex Huang | Investor Relations | Profile | |
| Ilya Goldshleger | Chief Officer | Profile | |
| Eric Weinberg | Chief Officer | Profile |
Already Invested in Rxsight?
The danger of trading Rxsight is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Rxsight is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Rxsight. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Rxsight is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Rxsight is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Rxsight Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Rxsight Stock. Highlighted below are key reports to facilitate an investment decision about Rxsight Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rxsight. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Rxsight Stock analysis
When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Transaction History View history of all your transactions and understand their impact on performance |
Is Rxsight's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rxsight. If investors know Rxsight will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rxsight listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Rxsight is measured differently than its book value, which is the value of Rxsight that is recorded on the company's balance sheet. Investors also form their own opinion of Rxsight's value that differs from its market value or its book value, called intrinsic value, which is Rxsight's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rxsight's market value can be influenced by many factors that don't directly affect Rxsight's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rxsight's value and its price as these two are different measures arrived at by different means. Investors typically determine if Rxsight is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rxsight's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.